These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25231834)

  • 1. Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.
    Bumb JM; Aksay SS; Janke C; Kranaster L; Geisel O; Gass P; Hellweg R; Sartorius A
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):227-32. PubMed ID: 25231834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
    Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
    Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
    Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECT seizure quality and serum BDNF, revisited.
    Sartorius A; Bumb JM; Aksay SS; Gass P; Hellweg R; Kranaster L
    Eur Arch Psychiatry Clin Neurosci; 2015 Jun; 265(4):359-60. PubMed ID: 25651974
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.
    Kranaster L; Hellweg R; Sartorius A
    Neurosci Lett; 2019 Jun; 704():164-168. PubMed ID: 30978454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
    Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
    Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
    Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
    J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only.
    Haghighi M; Salehi I; Erfani P; Jahangard L; Bajoghli H; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2013 Jul; 47(7):908-15. PubMed ID: 23583029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
    Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
    J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
    Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
    J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
    Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
    Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
    Ryan KM; Dunne R; McLoughlin DM
    Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of the brain-derived neurotrophic factor and dynamics of the seizure threshold of electroconvulsive therapy.
    Stephani C; Shoukier M; Ahmed R; Wolff-Menzler C
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):787-794. PubMed ID: 27787610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression: A Preliminary Report.
    Mindt S; Neumaier M; Hellweg R; Sartorius A; Kranaster L
    J ECT; 2020 Sep; 36(3):193-197. PubMed ID: 32118691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
    Freire TF; Fleck MP; da Rocha NS
    Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
    Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial.
    Carspecken CW; Borisovskaya A; Lan ST; Heller K; Buchholz J; Ruskin D; Rozet I
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):305-313. PubMed ID: 29847468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.